Fig. 6From: Naringenin alters the pharmacokinetics of ranolazine in part through the inhibition of cytochrome P450 (3A4) and P-glycoproteinThe movement of ranolazine in the rat-everted ileum from the serosal to mucosal side in the presence and absence of verapamil (n = 6). R, ranolazine; V, verapamilBack to article page